Category: JPN
PDF]US Food and Drug Administration Grants Breakthrough Therapy Designation for Mogamulizumab for the treatment of Mycosis Fungoides and Sézary Syndrome Kyowa Hakko Kirin News Releases
Daiichi Sankyo Obtains Approval in Japan for Additional Indication and Dosage for Ovisot® for Injection in Diagnosis of Vasospastic Angina – Media & Investors
Basic Accord on Gamification of Japanese Anime for Overseas Markets and Joint Publishing